203 related articles for article (PubMed ID: 31972353)
1. What does non-eligibility for myoma surgery mean in the context of sequential prescription of ulipristal acetate?
Pourcelot AG; Capmas P; Laberge P; Fernandez H
J Gynecol Obstet Hum Reprod; 2020 Apr; 49(4):101688. PubMed ID: 31972353
[TBL] [Abstract][Full Text] [Related]
2. Fibroid management in premenopausal women.
Donnez J; Courtoy GE; Dolmans MM
Climacteric; 2019 Feb; 22(1):27-33. PubMed ID: 30601065
[TBL] [Abstract][Full Text] [Related]
3. Which is the destiny of ulipristal acetate for uterine fibroids? A commentary on the Italian medicines agency (AIFA) pronouncements.
Indraccolo U; Conzadori S; Greco P
Recenti Prog Med; 2019 Feb; 110(2):98-99. PubMed ID: 30843536
[TBL] [Abstract][Full Text] [Related]
4. Does Ulipristal Acetate Affect Surgical Experience at Laparoscopic Myomectomy?
Luketic L; Shirreff L; Kives S; Liu G; El Sugy R; Leyland N; Solnik MJ; Murji A
J Minim Invasive Gynecol; 2017; 24(5):797-802. PubMed ID: 28351762
[TBL] [Abstract][Full Text] [Related]
5. Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids.
Szydłowska I; Marciniak A; Nawrocka-Rutkowska J; Rył A; Starczewski A
Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32012826
[No Abstract] [Full Text] [Related]
6. Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.
Pérez-López FR
Climacteric; 2015 Apr; 18(2):177-81. PubMed ID: 25390187
[TBL] [Abstract][Full Text] [Related]
7. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.
Talaulikar VS; Manyonda I
Womens Health (Lond); 2014 Nov; 10(6):565-70. PubMed ID: 25482483
[TBL] [Abstract][Full Text] [Related]
8. Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
Donnez J; Donnez O; Dolmans MM
Expert Opin Drug Saf; 2016 Dec; 15(12):1679-1686. PubMed ID: 27740868
[TBL] [Abstract][Full Text] [Related]
9. Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results.
Fernandez H; Schmidt T; Powell M; Costa AP; Arriagada P; Thaler C
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():91-96. PubMed ID: 27898340
[TBL] [Abstract][Full Text] [Related]
10. A Multicenter Study Evaluating the Effect of Ulipristal Acetate during Myomectomy.
Murji A; Wais M; Lee S; Pham A; Tai M; Liu G
J Minim Invasive Gynecol; 2018; 25(3):514-521. PubMed ID: 29079463
[TBL] [Abstract][Full Text] [Related]
11. Ulipristal acetate for uterine fibroid-related symptoms.
Puchar A; Luton D; Koskas M
Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
[TBL] [Abstract][Full Text] [Related]
12. Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
Ekanem E; Talaulikar V
Adv Ther; 2021 Jan; 38(1):137-148. PubMed ID: 33201387
[TBL] [Abstract][Full Text] [Related]
13. Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate.
Rabe T; Saenger N; Ebert AD; Roemer T; Tinneberg HR; De Wilde RL; Wallwiener M
Biomed Res Int; 2018; 2018():1374821. PubMed ID: 30539001
[TBL] [Abstract][Full Text] [Related]
14. First Impressions Can Be Deceiving: Surgical Outcomes of Laparoscopic Myomectomy in Patients Pretreated with Ulipristal Acetate.
Frascà C; Arena A; Degli Esposti E; Raimondo D; Del Forno S; Moro E; Zanello M; Mabrouk M; Seracchioli R
J Minim Invasive Gynecol; 2020; 27(3):633-638. PubMed ID: 31419494
[TBL] [Abstract][Full Text] [Related]
15. Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids.
Tafi E; Scala C; Leone Roberti Maggiore U; Bizzarri N; Candiani M; Venturini PL; Ferrero S
Expert Opin Drug Saf; 2015 Jun; 14(6):965-77. PubMed ID: 25772793
[TBL] [Abstract][Full Text] [Related]
16. Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.
Badiani B; Chiumente M; Messori A
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():84-88. PubMed ID: 29408752
[TBL] [Abstract][Full Text] [Related]
17. Ulipristal Acetate Before High Complexity Hysteroscopic Myomectomy: A Retrospective Comparative Study.
Ferrero S; Racca A; Tafi E; Alessandri F; Venturini PL; Leone Roberti Maggiore U
J Minim Invasive Gynecol; 2016; 23(3):390-5. PubMed ID: 26707918
[TBL] [Abstract][Full Text] [Related]
18. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study.
Ferrero S; Alessandri F; Vellone VG; Venturini PL; Leone Roberti Maggiore U
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():43-7. PubMed ID: 27566221
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of ulipristal acetate (UPA) for the treatment of expulsion uterine myomas: report of two cases.
Palaia I; Del Negro V; Fracassi A; Schiavi M; Di Donato V; Fischetti M; Muzii L; Benedetti Panici P
Gynecol Endocrinol; 2020 Jul; 36(7):660-661. PubMed ID: 31878806
[TBL] [Abstract][Full Text] [Related]
20. Myoma migration: an unexpected "effect" with Ulipristal acetate treatment.
Willame A; Marci R; Petignat P; Dubuisson J
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1439-44. PubMed ID: 27160112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
